Cargando…
A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway
BACKGROUND: Fyn has been documented to have oncogenic features in multiple tumors, which might be a potential therapeutic target, however, few studies on the function role of Fyn and its specific inhibitors in melanoma. METHODS: We investigated the impacts of Fyn and its inhibitor Lj-1-60 on melanom...
Autores principales: | Tang, Ling, Long, Jing, Li, Keke, Zhang, Xu, Chen, Xiang, Peng, Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302361/ https://www.ncbi.nlm.nih.gov/pubmed/32565740 http://dx.doi.org/10.1186/s12935-020-01336-2 |
Ejemplares similares
-
A novel chalcone derivative has antitumor activity in melanoma by inducing DNA damage through the upregulation of ROS products
por: Li, Keke, et al.
Publicado: (2020) -
Chalcone-imidazolone conjugates induce apoptosis through DNA damage pathway by affecting telomeres
por: Ramaiah, M Janaki, et al.
Publicado: (2011) -
UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
por: Zhou, Sitong, et al.
Publicado: (2021) -
CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway
por: Yuan, Wanqiong, et al.
Publicado: (2021) -
Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway
por: Li, Mei, et al.
Publicado: (2021)